So honoured to receive the 2021 ASCO Conquer Cancer, the ASCO Foundation-Lobular Breast Cancer Alliance Young Investigator Award supporting #lobular breast ca research!🙏 Grateful to my mentors & support @WCRInstitute Women's College Hospital David Urbach Simone Vigod Paula Rochon Thx esp to our patient advocate @CMcKay_CP🎉

Congratulations!

Being too busy can make us unhappy, but so can being too idle. New data: life satisfaction in the U.S. peaks at ~2-5hrs of free time per day. Time poverty fuels stress and burnout. Time abundance undermines purpose and progress. The sweet spot is time affluence: having enough.

via @NYTimes Dr. Walensky said providing booster shots to health care workers and others who risk contracting the disease on the job would “best serve the nation’s public health needs.” ⁦CDC Director⁩ well done!!! nytimes.com/2021/09/24/wor…

Green screen behind the plate in tonight’s ⁦Red Sox⁩⁩ #WildCard game is so distracting: same shape & color as an alphanumeric pager. I keep expecting it to pop up a message for some poor on-call MD to rewrite an #EMR order that accidentally got deleted 😝 #MedTwitter

I switched to iPhone fearing PTSD…

Thank you to UniMelb MDHS for your support. I’m looking forward to using the Snow Fellowship not only to do cutting-edge research, but also to help build training paths for the University’s next generation of clinician scientists. Snow Medical Tom Snow

Congratulations Shom! We’ll deserved! Looking forward to seeing phenomenal science coming from your lab. Really happy for you!!

Registration and abstract submission have opened! The Joint ELBCC & Lobular Breast Cancer Alliance #ILCSymposium and Summer School (19-20 June 2022). Free registration, limited space! See you in Utrecht! ilcsymposium2022.com LobularBCUK Lobular Breast Cancer IRL #LivingWithLobular Christine Desmedt Patrick WB Derksen #CA19138

⁦Lobular Breast Cancer Alliance⁩ Grateful to be able contribute. Thank you so much

#ASCO22 wonderful to see so many friends! Back to Boston to the great Dana Farber Dana-Farber’s Breast Oncology Center

Welcome back Paul! Boston loves you!!!

The Lobsterpot #CA19138 core group discussing the ongoing AND next steps in #ILC research TOGETHER with our US partners Dr. Steffi Oesterreich and Otto Metzger . The first feat of arms of the #ILCSYMPOSIUM !ilcsymposium2022.com

Morning rounds

Vote for this great team Dr. E Mittendorf @SandraMcAllist4 Brigham and Women's Hospital to fund their exciting and important work on racial differences in the immune system and development of breast cancer Brigham and Women’s Research

Just minted :) A llyb mehdi movahed findmory 🦇⭐️ M0nst3rCrypt Emmanuel Maxiem-Art Maine KartR Design master @BuzzTechYear Artem Asliddin Dilmurodov

Thanks Adidas :) Nifty Fren (🔲,🔮 ,🦉, 🥃 ) Sean.BlackLivesMatter Universal Cash Lisa hagihacci Jamie Dempsey Lya from Territorio de Zaguates @arsonNFT okeyboomer Nature25 ⌘ Dr Kadiri Adaba Juan Theron bubz

OMG NICE :) ALOK SHUKLA HannaWan GanyuSimp404 Alex Bush Julie Wittman Rita Hellmuth Paraskiz @_Raphael9x74 bittersw33t Natalie Reyes francine jayne @Bepyneth peppe.eth

At #SABCS24 Dana-Farber’s Otto Metzger, MD, presented late-breaking results of the phase 3 PATINA trial showing addition of palbociclib to standard therapy led to a 15-month improvement in PFS in HR+, HER2+ metastatic breast cancer. Dana-Farber’s Breast Oncology Center bit.ly/41Dj25A

Now on #SABCSSnippets: Lisa Carey, MD, ScM, FASCO and Otto Metzger, MD, discuss the phase 3 PATINA trial, which showed that patients with HR+, HER2+ metastatic breast cancer had improved PFS when palbociclib was added to endocrine and anti-HER2 therapy. bit.ly/3Zs3kYw #SABCS24